secwatch / observer
8-K filed February 3, 2022, 6:59 PM ET ticker DGX CIK 0001022079
leadership confidence high sentiment neutral materiality 0.75

Quest Diagnostics appoints James E. Davis as CEO-elect; CFO Mark Guinan to retire in 2022

QUEST DIAGNOSTICS INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark J. Guinan

Executive Vice President and Chief Financial Officer
DGX · QUEST DIAGNOSTICS INC
Filed
February 3, 2022, 6:59 PM ET
Mark J. Guinan, the Company’s Executive Vice President and Chief Financial Officer, will retire in 2022.
Role change

Stephen H. Rusckowski

Executive Chairman
DGX · QUEST DIAGNOSTICS INC
Effective
2022-11-01
Successor
James E. Davis
Filed
February 3, 2022, 6:59 PM ET
Mr. Rusckowski, 64, currently Chairman, Chief Executive Officer and President, will continue to serve on the Board as Executive Chairman through March 2023.
Appointed

James E. Davis

Chief Executive Officer – Elect
DGX · QUEST DIAGNOSTICS INC
Effective
2022-02-03
Filed
February 3, 2022, 6:59 PM ET
appointed James E. Davis, currently Executive Vice President, General Diagnostics, to be its next Chief Executive Officer and President, effective November 1, 2022. In addition, Mr. Davis was appointed Chief Executive Officer – Elect, effective February 3, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark J. Guinan departed as Executive Vice President and Chief Financial Officer at QUEST DIAGNOSTICS INC.

Action
will retire
Role
Executive Vice President and Chief Financial Officer
Exact text from the filing
Mark J. Guinan, the Company’s Executive Vice President and Chief Financial Officer, will retire in 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen H. Rusckowski changed role as Executive Chairman at QUEST DIAGNOSTICS INC.

Action
will serve as Executive Chairman
Role
Executive Chairman
Exact text from the filing
Mr. Rusckowski, 64, currently Chairman, Chief Executive Officer and President, will continue to serve on the Board as Executive Chairman through March 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

James E. Davis was appointed as Chief Executive Officer – Elect at QUEST DIAGNOSTICS INC.

Action
appointed
Role
Chief Executive Officer – Elect
Exact text from the filing
appointed James E. Davis, currently Executive Vice President, General Diagnostics, to be its next Chief Executive Officer and President, effective November 1, 2022. In addition, Mr. Davis was appointed Chief Executive Officer – Elect, effective February 3, 2022.
View on SEC.gov

QUEST DIAGNOSTICS INC filing history →

Source: SEC EDGAR
accession 0000947871-22-000132
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.